skip navigation

PUBLICATIONS

Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.

 

NCJ Number: 119502 Find in a Library
Title: Prescription Drugs: Information on Selected Drug Utilization Review Systems
Corporate Author: US Government Accountability Office
Program Evaluation and Methodology Division
United States of America
Date Published: 1989
Page Count: 11
Sponsoring Agency: Azimuth Inc.
Fairmont, WV 26554
National Institute of Justice/
Rockville, MD 20849
NCJRS Photocopy Services
Rockville, MD 20849-6000
US Government Accountability Office
Washington, DC 20548
Publication Number: GAO/PEHD-89-18
Sale Source: Azimuth Inc.
1000 Technology Drive, Suite 3120
Fairmont, WV 26554
United States of America

National Institute of Justice/
NCJRS paper reproduction
Box 6000, Dept F
Rockville, MD 20849
United States of America

NCJRS Photocopy Services
Box 6000
Rockville, MD 20849-6000
United States of America
Document: PDF
Type: Legislative Hearing/Committee Report
Language: English
Country: United States of America
Annotation: This document reviews the implementation plans proposed by the Health Care Financing Administration (HCFA) for the drug utilization review (DUR) system required to be established under the Medicare Catastrophic Coverage Act of 1988.
Abstract: Seven different pharmacy systems were examined to determine how they compare with the provisions specified under the Act. The focus was specifically on the extent to which these DUR systems could identify adverse reactions that may result from the interaction of the prescribed drug with one or several other drugs, a known allergy, a known physical condition or illness present in the beneficiary, or over-the-counter drugs; incorrect dosages; and under- and over-utilization of the prescribed drug. Also focused upon were the types of drug and patient data, which included the drug name, dosages, quantities, methods of administration, last date dispensed, and information on diagnosis/condition. It was found that all the attributes of a DUR system and the patient profile information of interest were currently available in at least some operating DUR systems. Issues of data security were dealt with by all systems.
Main Term(s): Controlled Substances
Index Term(s): Drug information; Drug testing; Drug use
To cite this abstract, use the following link:
http://www.ncjrs.gov/App/publications/abstract.aspx?ID=119502

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.